The complete side effect frequency breakdown from Phase 2 trials: Very Common (20%+ of patients at 12mg dose) Nausea: 28% Typically mild to moderate, peaks weeks 4-8, usually resolves by week 12 Diarrhea: 24% Usually transient (1-3 weeks), rarely severe Constipation: 21% Paradoxically coexists with diarrhea in different patients Common (10-20% of patients) Vomiting: 17% Decreased appetite: 16% (beyond therapeutic effect) Injection site reactions: 14% Fatigue: 13% Dyspepsia (indigestion): 12% Headache: 11% Uncommon (2-10% of patients) Abdominal pain: 8% Dizziness: 7% Gastroesophageal reflux: 6% Hypoglycemia in diabetics on other medications: 5% Increased heart rate (average 2-4 bpm): 4% Hair thinning/loss: 3% (typically temporary) Rare but Serious (Under 2%) Pancreatitis: 0.3% (3 cases out of 1,032 patients, all resolved with discontinuation) Gallbladder events: 1.4% (expected with rapid weight loss regardless of method) Acute kidney injury: 0.7% (all cases associated with severe dehydration) KEY TAKEAWAY: About 30% experience meaningful nausea in the first 4-8 weeks

Q8: Is DSIP medical advice
Follow Recommended Dosages : Always adhere to recommended dosages provided by your healthcare professional or the product label
It's entirely up to you and your project's needs
Using advanced neuroimaging techniques, his team demonstrated that patients with ME/CFS have significantly depleted levels of cortical glutathione compared to healthy controls
Glutathione is the most abundant intracellular thiol (i.e ., a compound containing a sulfhydryl [SH] group) and low molecular weight tripeptide found in living cells." The antioxidant functions of Glutathione Reduced include recycling vitamins E and C and serving as an antioxidant in all types of tissues